John P. Overington
Alderley Edge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Journal: The Cochrane database of systematic reviews
Published: October 20, 2020
Artificial intelligence, drug repurposing and peer review.
Journal: Nature biotechnology
Published: September 15, 2020
Setting Our Sights on Infectious Diseases.
Journal: ACS infectious diseases
Published: December 07, 2019
Improving the odds of drug development success through human genomics: modelling study.
Journal: Scientific reports
Published: March 01, 2019
Meeting the discovery challenge of drug-resistant infections: progress and focusing resources.
Journal: Drug discovery today
Published: July 30, 2018
Unexplored therapeutic opportunities in the human genome.
Journal: Nature reviews. Drug discovery
Published: March 24, 2018
Unexplored therapeutic opportunities in the human genome.
Journal: Nature reviews. Drug discovery
Published: February 24, 2018
Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling.
Journal: Journal of chemical information and modeling
Published: November 28, 2017
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.
Journal: Cell chemical biology
Published: August 22, 2017
Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach.
Journal: Frontiers in pharmacology
Published: July 24, 2017
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Journal: The Cochrane database of systematic reviews
Published: April 29, 2017
Last Updated: 09/26/2026